Business
Cytokinetics Outlines Vision 2030 Pipeline Ambitions at Bernstein Forum
The cardiac drug developer targets two approved therapies across three indications and 10 new molecular entities by 2030, as MYQORZO commercial momentum continues.
General Mills Beats Q1 Estimates but Shares Slip on Share-Growth Concerns
General Mills reported Q1 adjusted EPS of $0.75 and revenue of $4.4 billion, topping estimates, but shares fell in premarket trading as management cautioned that dollar-share growth remains incomplete.
Moderna Accelerates mRNA Push Beyond COVID at Bernstein Healthcare Forum
The company disclosed $2.6 billion in convertible-note funding, pipeline advances in cancer and rare-disease programs, and reported $2.23 billion in trailing revenue as its mRNA platform strategy broadens.
Liechtensteinische Landesbank launches "elevate" strategy with steady financial targets
LLB unveils a growth‑focused plan that keeps 3% net cash inflow and 65% cost‑income ratio goals, adds an Austrian acquisition and exits the Gulf market.
Atomo Diagnostics posts 41% revenue growth as FY2026 loss narrows
Australian diagnostic company Atomo reported AUD 5.3 million in revenue for FY2026, up 41% year-over-year, with OEM product sales surging more than 200% driven by the Lumos Diagnostics partnership.
Sunrise CEO: Certain jobs will no longer exist, up to 450 positions at risk
Swiss telecom Sunrise plans to trim up to 450 jobs as it shifts growth strategy toward cloud, cybersecurity and AI. CEO says some current roles will disappear entirely.
Fonterra Beats Return Target in H2 2026, Eyes FY 2027 Guidance
The dairy cooperative reported that its return on capital exceeded the 10%–12% target range, citing strong stream returns and commodity tailwinds, while noting logistics challenges in the Middle East and plans for further investment.
Fonterra posts strong H2 2026, sees FY27 guidance hinge on stream returns
Fonterra reported FY26 return on capital above its 10%‑12% target, shares steady around $4.85, and said FY27 outlook depends on dairy stream return trends and shipping costs.
Elixirr AI Revenue Surges 185% as EBITDA Margin Tops 31% in H1 2026
Management consultant Elixirr reported H1 revenue of £89 million, up 25%, with adjusted EBITDA of £27.6 million. The London-listed firm saw AI-related income jump 185% year-over-year to roughly £8 million.
Elixirr H1 2026: AI revenue surges 185%, but valuation gap widens
London consultancy reports £89m revenue and strong AI growth, but says share price has not kept pace with sustained revenue outperformance versus the FTSE 100.
Palazzo Venezia offers boutique luxury on Lake Como
The 5‑star Palazzo Venezia, part of the Leading Hotels of the World, opened after its acquisition by Villa d’Este La Collezione and features 18 rooms, a rooftop bar and the Altariva restaurant.
CBAK Energy to Build 12-GWh Sodium-Ion Battery Facility in Nanjing
CBAK Energy signed an agreement to construct a 12-GWh sodium-ion battery cell plant in Nanjing, targeting production advances in H2 2027, alongside a planned 6-GWh expansion of its existing site in H2 2026.
Protolabs Robotics Revenue More Than Doubles in First Half 2026
Minneapolis-based Protolabs says robotics-customer revenue more than doubled in H1 2026 versus the prior-year period, as the global robotics market is projected to grow at a 20% compound annual rate through 2031.
Flywire Appoints Former GitLab CTO Sabrina Farmer to Board
Flywire adds Sabrina Farmer, Microsoft commerce platform VP and ex-GitLab CTO, to its board and governance committee, citing her experience building systems at scale.
Optimi Completes Psilocybin Capsule Batch for Australian Depression Trial
Optimi Health has manufactured a cGMP batch of 5mg psilocybin capsules at its Princeton facility for a multisite study treating treatment-resistant depression in Australia.
Limbach Holdings Appoints Adam Prior as Vice President of Investor Relations and Corporate Strategy
Limbach Holdings Inc. named Adam Prior to lead investor relations and corporate strategy, drawing on more than 25 years of experience. The appointment was announced on Tuesday, September 23, 2026.
Meta AI Glasses to Capture Dolby Atmos Audio, Dolby Vision Set for 2027 VR Device
The partnership expands Dolby technologies across Meta's devices, with the AI glasses becoming the first consumer product to record spatial audio and the upcoming VR headset slated for 2027 to support both Dolby Vision and Atmos.
Accenture Invests in AI Process-Mapping Firm Within
Accenture Ventures takes stake in Within, an AI platform that maps and automates enterprise business processes. Financial terms were not disclosed.
Lokahi Therapeutics Files Trial Protocol for Osteoarthritis Drug LT-100
The Glucotrack subsidiary targets regulatory approval for its biologic candidate ahead of a once-weekly subcutaneous injection trial for knee osteoarthritis pain.
MoonPay to Acquire North Capital in Over $60M All-Stock Deal
The crypto payments company buys a US-regulated securities infrastructure provider, expanding into tokenized real-world assets and private securities trading.
Apollo Targets $50B Trading Volume as Liquid Private Markets Push Gains Momentum
Apollo CEO Marc Rowan says the firm expects over $50 billion in annual trading volume for its liquid private-markets segment by year-end, as the $1.15 trillion asset manager accelerates its shift toward daily-priced, transparent products.
Bank of America sets AI, growth and capital targets at CEO conference
At its 31st Financials CEO Conference, Bank of America highlighted a 70‑million client base, AI tools for 200,000 staff and a $4 billion international revenue opportunity.
Buck Institute Partners With Oracle for Aging Research Initiative
The Buck Institute for Research on Aging will use Oracle's Life Sciences Data Intelligence platform, which holds over 122 million de-identified longitudinal health records, to study age-related diseases and build an FDA-grade "intrinsic capacity score."
Holley Performance Brands Makes $10 Million Voluntary Debt Prepayment
The automotive parts maker used free cash flow to prepay $10 million of its term loan, bringing total debt reduction since September 2023 to $125 million. CFO Jesse Weaver said the move keeps the company on track to hit a year-end leverage ratio below 3.5x.
UiPath Enhances Test Cloud with AI-Powered Testing Tools
UiPath, Inc. (NYSE: PATH) announces AI-powered enhancements to its Test Cloud platform, including UiPath Autopilot and autonomous exploration tools, aimed at automating software testing processes.